Prof. Dr. Rongxi Yang
Department of Epidemiology, School of Public Health
Nanjing Medical University.
杨蓉西博士 教授
Rongxi Yang, PhD
Research Interest
Molecular epidemiology, Genetic/epigenetics and Cancer, Molecular diagnosis, In-vitro diagnosis
Education and Professional Experience
Beijing Normal Universtiy, Biological Sciences, B.S. (2000.9-2004.7)
University of Heidelberg, Germany, Molecular and Cellular Biology, M.S. (2006.10-2008.1)
German Cancer Research Center, Germany, Molecular Epidemiology, Ph.D (2007.3-2011.2)
German Cancer Research Center, Germany, Molecular Epidemiology, Postdoc (2010.3-2012.3)
University Hospitals of Heidelberg, Germany, Molecular Epidemiology, Project leader (2012.3-2015.12)
University Hospitals of Heidelberg, Germany, Head of Mamma Screen Translational group, Independent PI (2016.1-2017.6)
Honors and Awards
2016 Breast Cancer Research Junior Award 2016 by Claudia von Schilling Foundation(one person per year in Germany, Switzerland, and Austria)
2016 First Price of the 2016 "Health Innovation Pitches" internationalphase, EU
2016 First Price of the 2016 "Health Innovation Pitches" German nationalphase, Germany
Ongoing Research Projects
Translational and Innovation Project of Jiangsu Province (Teams)
Translational and Innovation Project of Jiangsu Province (Individuals)
Distinguished Professor Project of Jiangsu Province
National Excellence Project (Junior project)
Selected Papers
ChunlanLiu，~,Yang R*.The Association Between Breast Cancer and Blood-Based Methylation of CD160, ISYNA1 and RAD51B in the Chinese Population. Frontiers in Genetics.2022.
ChunlanLiu, ~, Yang R*.ACTB methylation in blood as a potential marker for the pre-clinical detection of stroke: a prospective nested case-control study.Frontiers in Neuroscience.2021
Yang R#*,et al. The association between breast cancer and S100P methylation inperipheral blood by multi-center case-control studies.Carcinogenesis.2017.
